Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Neuraxis, Inc.

6.90
-0.1000-1.43%
Post-market: 6.950.0500+0.72%18:49 EDT
Volume:151.66K
Turnover:1.03M
Market Cap:77.19M
PE:-7.26
High:7.00
Open:6.88
Low:6.55
Close:7.00
52wk High:7.97
52wk Low:1.33
Shares:11.19M
Float Shares:7.53M
Volume Ratio:0.59
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9500
EPS(LYR):-0.9500
ROE:-285.36%
ROA:-80.63%
PB:22.73
PE(LYR):-7.26

Loading ...

OverviewCompanyNewsFilings

Press Release: NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Dow Jones
·
Nov 11, 2025

Neuraxis Q3 EPS $(0.24) Misses $(0.17) Estimate, Sales $811.414K Miss $1.000M Estimate

Benzinga
·
Nov 11, 2025

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), NeurAxis, Inc. (NRXS) and Celcuity (CELC)

TIPRANKS
·
Nov 10, 2025

NeurAxis Inc. to Release Third Quarter 2025 Results

Reuters
·
Nov 04, 2025

Neuraxis received FDA 510k clearance for PENFS technology

TIPRANKS
·
Oct 24, 2025

NeurAxis Wins FDA Clearance for First Adult Functional Dyspepsia Pain Device

Reuters
·
Oct 24, 2025

Neuraxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) With Associated Nausea Symptoms in the Adult Patient Population

THOMSON REUTERS
·
Oct 24, 2025

NeurAxis Inc. reports $0.8 million net sales and $2.1 million operating loss for Q3 2025

Reuters
·
Oct 24, 2025

Craig-Hallum Reaffirms Their Buy Rating on NeurAxis, Inc. (NRXS)

TIPRANKS
·
Sep 25, 2025

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Mar 19, 2026 Pre-Market
Financial Report Announcement
Nov 11, 2025 Pre-Market
Financial Report Announcement
May 12, 2025 Pre-Market
Financial Report Announcement
Nov 12, 2024 Pre-Market
Financial Report Announcement
May 22, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-7.25
Current
-2.87
Sector Average
0.00%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-7.25
Maximum
-1.14
+1 STD
-1.02
Minimum
-10.77
-1 STD
-4.71
Average
-2.87

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.